Mylan has issued a nationwide voluntary recall of injectable amiodarone, an antiarrhythmic for in-hospital use, that may have been mislabeled as tranexamic acid injection, according to the US Food and ...

Credit: FDA. The FDA has received reports of tranexamic acid injection being erroneously administered intrathecally in the perioperative setting instead of the intended intrathecal anesthetic (eg, ...

The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...

Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, announces the approval of an Abbreviated New Drug Application (ANDA) 1 for Tranexamic Acid Injection 1000 mg/10mL (100 mg/mL). The Food ...

Along with the boxed warning, FDA will require a statement on product labeling indicating that TXA injection is contraindicated as a neuraxial injection, and have the dose and administration section ...

Represents the Company’s tenth product launch since inception in October 2023 SCHAUMBURG, Ill., June 24, 2024--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Inadvertent administration may result in serious adverse events. Mylan announced the voluntary recall to the hospital/clinic level of 4 lots of Amiodarone HCl Injection, USP 450mg/9mL and Tranexamic ...

Aurobindo Pharma has received final approval from the USFDA to manufacture and market its Tranexamic acid injection, used for treating hemophilia, in the American market. The company plans to launch ...

(RTTNews) - Generic and specialty pharma company Mylan N.V. said its U.S.-based business Mylan Institutional LLC recalled four lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Tranexamic Acid Injection, USP in ...